Eye drops containing a .beta.-blocker such as cartelol hydrochloride are improved in the penetration of the .beta.-blocker into the eye and the retention thereof in the eye tissues by the incorporation of a C.sub.3-7 fatty acid such as sorbic acid to the eye preparations.

Des baisses d'oeil contenant un beta.-dresseur tel que le chlorhydrate de cartelol sont améliorées dans la pénétration du beta.-dresseur dans l'oeil et la conservation en dans les tissus d'oeil par l'incorporation d'un acide gras C.sub.3-7 tel que l'acide sorbique aux préparations d'oeil.

 
Web www.patentalert.com

< Drug delivery system exhibiting permeability control

< Polynucleotides encoding a novel metalloprotease, MP-1

> (7-(3-carboxyphenyl)-4-chloroisoquinolin-1-yl)guanidine

> Electrical field therapy with reduced histopathological change in muscle

~ 00090